All data are based on the daily closing price as of September 1, 2025
t
Towa Pharmaceutical
4553.TSE
20.00 USD
0.27
+1.37%
Overview
Last close
20.00 usd
Market cap
984.34M usd
52 week high
23.11 usd
52 week low
16.24 usd
Target price
26.66 usd
Valuation
P/E
7.5188
Forward P/E
16.7785
Price/Sales
0.5445
Price/Book Value
0.8265
Enterprise Value
2.23B usd
EV/Revenue
1.2624
EV/EBITDA
6.8194
Key financials
Revenue TTM
1.78B usd
Gross Profit TTM
646.54M usd
EBITDA TTM
295.11M usd
Earnings per Share
2.62 usd
Dividend
0.48 usd
Total assets
3.16B usd
Net debt
1.24B usd
About
Towa Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sale ethical drugs in Japan. It operates through two segments; Domestic and Overseas. The company provides its products in the therapeutic areas of digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products, as well as provide formulations from Tablets, Capsules, Injectable, Patches, eye drops, and other products. It also offers IT service related to healthcare; disease risk testing services; and quasi drugs. In addition, the company is involved in research and development and production of active pharmaceutical ingredients, intermediates, support business; and planning, development and OEM manufacturing of health foods, pharmaceuticals, general foods, and other miscellaneous merchandizes. The company was founded in 1951 and is headquartered in Osaka, Japan.